Eureka AIR delivers breakthrough ideas for toughest innovation challenges, trusted by R&D personnel around the world.

Application of glucogalactooligosaccharide in preparation of medicine for treating and/or preventing ischemia-reperfusion injury

A technology of galacto-oligosaccharides and ischemia-reperfusion, which is applied in drug combinations, pharmaceutical formulas, cardiovascular system diseases, etc., to achieve the goal of reducing cognitive dysfunction, strong drug efficacy, and reducing renal ischemia-reperfusion injury Effect

Active Publication Date: 2021-09-28
NANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD
View PDF1 Cites 1 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, whether the galactooligosaccharide has a protective effect on ischemia-reperfusion injury has not been reported yet.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Application of glucogalactooligosaccharide in preparation of medicine for treating and/or preventing ischemia-reperfusion injury
  • Application of glucogalactooligosaccharide in preparation of medicine for treating and/or preventing ischemia-reperfusion injury
  • Application of glucogalactooligosaccharide in preparation of medicine for treating and/or preventing ischemia-reperfusion injury

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0041] Protective effect of glucogalactooligosaccharides on hepatic ischemia-reperfusion injury

[0042] 1. Establishment of animal models

[0043] The experimental animals are male C57 / BL6J mice, 6-8 weeks old, 22-26g. Raised under standard experimental conditions, 12-hour light-12-hour dark cycle, free access to water and food. The mice were anesthetized with isoflurane, and the abdomen was operated on, and the blood supply of the middle lobe and left lobe of the liver was blocked with a non-traumatic hemostatic clip, resulting in 70% liver ischemia. After 30 min of ischemia, the clip was removed, and then reperfused After 6 hours, samples were taken to measure biochemical indicators.

[0044] 2. Experimental grouping

[0045]By intraperitoneal injection, the mice were randomly divided into four groups, the first group was the sham operation group (sham), the animals in the sham operation group received the same laparotomy, but no vascular clip was blocked; the second gro...

Embodiment 2

[0056] Protective effect of glucogalactooligosaccharides on renal ischemia-reperfusion injury

[0057] 1. Establishment of animal models

[0058] The experimental animals were male C57 / BL6J mice, 6-8 weeks old, 22-26g. The mice were anesthetized with isoflurane, and the abdomen was operated on. Under sterile conditions, a 1.5 cm longitudinal incision was made along the double dorsal side to enter the abdominal cavity, the muscles were bluntly separated, and the renal pedicles on both sides were exposed. After 30 minutes of ischemia, the arterial clamp was released, and the abdominal cavity was closed after the renal perfusion resumed. After 24 hours, samples were taken to measure biochemical indicators, so as to establish the RIRI model.

[0059] 2. Experimental grouping

[0060] By intraperitoneal injection, the mice were randomly divided into four groups, the first group was the sham operation group (sham), the animals in the sham operation group received the same laparoto...

Embodiment 3

[0071] The protective effects of glucogalactooligosaccharides against cerebral ischemia-reperfusion injury.

[0072] 1. Establishment of animal models

[0073] The experimental animals are male C57 / BL6J mice, 6-8 weeks old, 22-26g. Anesthetize mice with isoflurane and place them supine on a heating pad. The skin was disinfected with iodine and 75% ethanol. A midline neck incision was made to expose the carotid artery (MCA). The external carotid artery (ECA) was then isolated and occluded with two knots. Next, the internal carotid artery (ICA) was isolated, and the carotid artery (MCA) and internal carotid artery (ICA) were clamped with microvascular clamps. A small hole was cut in the external carotid artery (ECA) between the junction and the bifurcation. Then, the MCAO suture with a length of 30 mm and a diameter of 0.11 mm coated with silicone rubber was introduced into the internal carotid artery (ICA). While sutures are inserted to block the blood vessel, the artery ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses an application of glucogalactooligosaccharide in preparation of a medicine for treating and / or preventing ischemia-reperfusion injury. The glucogalactooligosaccharide disclosed by the invention can be used for remarkably relieving postoperative liver injury, kidney injury, brain injury and the like of ischemia reperfusion mice, is safe and non-toxic, has a strong drug effect, and has a very good medicinal prospect in prevention and treatment of ischemia reperfusion injury.

Description

technical field [0001] The invention belongs to the technical field of drugs for ischemia-reperfusion injury, and relates to the application of glucogalactooligosaccharide in the preparation of drugs for treating and / or preventing ischemia-reperfusion injury. Background technique [0002] Ischemia-reperfusion injury (IRI) refers to the phenomenon that tissue and organ ischemia and reperfusion cannot restore its function, but aggravate the dysfunction and structural damage of tissues and organs. The pathogenesis of ischemia-reperfusion involves multiple mechanisms, including activation of neutrophils, oxidative stress, ATP and glycogen depletion, and cellular metabolic stress due to mitochondrial dysfunction. The mechanism of this pathophysiological process is complex, and there is still a lack of comprehensive and effective treatment methods and specific drugs for ischemia-reperfusion injury clinically. The liver, kidney, and brain are common organs that are injured by isch...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K31/715A61P9/10
CPCA61K31/715A61P9/10A61K9/0019A61K47/02A61K47/26
Inventor 张建法王妮赵扬
Owner NANJING SOUTHERN ELEMENT BIOTECHNOLOGY CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Eureka Blog
Learn More
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com